Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valérie Audinot

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Medecine Sciences : M/S|October 17, 2012
[G-protein-coupled receptors, the beginning of a new era for therapeutic innovation]Antoine Bril, Murielle Combettes, Valérie Audinot
Trends in Pharmacological Sciences|July 5, 2005
Molecular tools to study melatonin pathways and actionsJean A Boutin, Valérie Audinot, Gilles Ferry, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypesMark J Millan, Lisa Maiofiss, Didier Cussac, et al.
The Journal of Biological Chemistry|November 8, 2002
Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genisteinZhi-Chao Dang, Valérie Audinot, Socrates E Papapoulos, et al.
Frontiers in Endocrinology|December 26, 2012
Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity modelsOdile Della-Zuana, Valérie Audinot, Viviane Levenez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligandsIsabelle Charton, Franck Suzenet, Jean A Boutin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2005
Synthesis of new carbo- and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARsFrédéric Caijo, Paul Mosset, René Grée, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptorAdrian Newman-Tancredi, Didier Cussac, Valérie Audinot, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptorsCarlos Larraya, Jérôme Guillard, Pierre Renard, et al.
Canadian Journal of Physiology and Pharmacology|June 12, 2002
Melanin-concentrating hormone and its receptors: state of the artJean A Boutin, Thomas Suply, Valérie Audinot, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Medecine Sciences : M/S|October 17, 2012
[G-protein-coupled receptors, the beginning of a new era for therapeutic innovation]Antoine Bril, Murielle Combettes, Valérie Audinot
Trends in Pharmacological Sciences|July 5, 2005
Molecular tools to study melatonin pathways and actionsJean A Boutin, Valérie Audinot, Gilles Ferry, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypesMark J Millan, Lisa Maiofiss, Didier Cussac, et al.
The Journal of Biological Chemistry|November 8, 2002
Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genisteinZhi-Chao Dang, Valérie Audinot, Socrates E Papapoulos, et al.
Frontiers in Endocrinology|December 26, 2012
Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity modelsOdile Della-Zuana, Valérie Audinot, Viviane Levenez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis of 5-substituted-2,3-dihydro-1,4-benzoxathiins: biological evaluation as melatonin receptors ligandsIsabelle Charton, Franck Suzenet, Jean A Boutin, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2005
Synthesis of new carbo- and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARsFrédéric Caijo, Paul Mosset, René Grée, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2002
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. II. Agonist and antagonist properties at subtypes of dopamine D(2)-like receptor and alpha(1)/alpha(2)-adrenoceptorAdrian Newman-Tancredi, Didier Cussac, Valérie Audinot, et al.
European Journal of Medicinal Chemistry|June 9, 2004
Preparation of 4-azaindole and 7-azaindole dimers with a bisalkoxyalkyl spacer in order to preferentially target melatonin MT1 receptors over melatonin MT2 receptorsCarlos Larraya, Jérôme Guillard, Pierre Renard, et al.
Canadian Journal of Physiology and Pharmacology|June 12, 2002
Melanin-concentrating hormone and its receptors: state of the artJean A Boutin, Thomas Suply, Valérie Audinot, et al.
Pageof 4